Karen H. Vousden

Non Executive / Other Non-Executive
Login/ Register  to follow report
Company:

About

Dr. Vousden, age 66, has been a senior group leader at The Francis Crick Institute in London since February 2017 and served as the chief scientist of Cancer Research UK (CRUK) between 2016-2022.

Dr. Vousden brings to the Board more than 30 years of experience leading groundbreaking cancer research. She is a fellow of the Royal Society and a foreign associate of the National Academy of Sciences. She serves as a member of the Science Advisory Boards of Kovina Therapeutics, the University Cancer Center Frankfurt, Ludwig Institute for Cancer Research, PMV Pharma, Raze Therapeutics, Swiss Institute for Experimental Cancer Research, and Volastra Therapeutics. Dr. Vousden serves as president of the British Association of Cancer Research.

She is founder and consultant of Faeth Therapeutics, Inc., a fellow of the Royal Society and a foreign associate of the National Academy of Sciences.

 

Personal Details

Title: Dr
Surname: Vousden
DoB: 01/01/1957
Age: 69 years
M/F: Female
Nationality: United Kingdom
Country of Birth: United Kingdom of Great Britain and Northern Ireland
Language: English
Qualification: PhD
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

 

Working history

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Bristol Myers SquibbBoardMember

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF